Prognostic Value of albumin-bilirubin (ALBI) Grade in Patients with Gastric Cancer: A Systematic Review and meta-analysis [0.03%]
胃癌患者血清白蛋白-胆红素(ALBI)分级预后价值的系统评价和 Meta 分析
Mahyaar Omouri-Kharashtomi,Hamed Ghoshouni,Ariyan Ayati Firoozabadi et al.
Mahyaar Omouri-Kharashtomi et al.
Background: Gastric cancer (GC) is considered a leading cause of cancer-related deaths. Identifying patients with poor survival outcomes and factors related to prognosis are crucial measures in patient care. In addition t...
Sintilimab Plus Nanoparticle Polymeric Micellar Paclitaxel and S-1 as First-Line Treatment in HER2-Negative Advanced Gastric Cancer: A Real-World Study [0.03%]
信迪利单抗联合聚乙二醇化白蛋白紫杉醇和替吉奥三药一线治疗HER2阴性晚期胃癌的回顾性分析
Yu-Qing Cao,Meng Song,Xiang-Ming Huang et al.
Yu-Qing Cao et al.
Background: This study evaluated the efficacy and safety of a regimen consisting of sintilimab, nanoparticle polymeric micellar paclitaxel (NPMP) and S-1 in HER2-negative advanced gastric cancer (AGC). ...
Global Burden and Future Trends of Gastrointestinal Cancers in Adolescents and Young Adults, 1990-2045: A Predictive Analysis [0.03%]
1990年至2045年青少年和青年人胃肠癌症的全球疾病负担及未来趋势：预测性分析
Longxiu Fan,Zhen Liu,Qili Xiao et al.
Longxiu Fan et al.
Purpose: Gastrointestinal (GI) cancers significantly contribute to the global cancer burden, yet their epidemiological trends among adolescents and young adults (AYAs: aged 15-39 years) remain understudied. This study pro...
Effect of Dietary Interventions on Body Composition and Quality of Life in Stomach Cancer Survivors after Gastrectomy: A Systematic Review [0.03%]
饮食干预对胃癌术后患者身体 composition和生命质量影响的系统评价
Abhishek Anand,T R Dilip,Leone Craig et al.
Abhishek Anand et al.
Purpose: Nutritional interventions are critical in supporting recovery and maintaining nutritional status in gastric cancer patients post-gastrectomy. This systematic review evaluates the impact of various dietary interve...
Outcomes of Ramucirumab Monotherapy for Advanced Gastric Cancer in a Multi-institutional Cohort Study in Japan [0.03%]
瑞戈非尼单药治疗晚期胃癌的多中心队列研究的疗效和安全性分析
Yoshinori Kikuchi,Sakae Nagaoka,Nobue Futawatari et al.
Yoshinori Kikuchi et al.
Purpose: The REGARD trial resulted in insurance approval for ramucirumab monotherapy; however, it did not include Japanese patients. Subsequent phase II trials and retrospective studies have examined Japanese cohorts, but...
Multicenter Study
Journal of gastrointestinal cancer. 2026 Jan 13;57(1):10. DOI:10.1007/s12029-026-01396-z 2026
Changing Perspectives in Managing Metastatic Gallbladder Cancer: Defining Oligometastatic Disease, Current Treatments, and Emerging Therapies [0.03%]
转移性胆囊癌管理中的视角变化：界定寡转移性疾病、当前治疗方法和新兴疗法
Kailash Chand Kurdia,Alessandro Coppola,Spiros Delis et al.
Kailash Chand Kurdia et al.
Background: Oligometastasisdisease (OMD) is an intermediate stage between localised disease and widespread metastasis. No standard OMD definition exists for gallbladder cancer (GBC). This review examines OMD definitions i...
Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment [0.03%]
DAA治疗后实现SVR的HCV相关肝硬化患者糖皮质激素结合蛋白-3的诊断和预后价值的回顾性分析
Gian Paolo Caviglia,Marta Guariglia,Silvia Gaia et al.
Gian Paolo Caviglia et al.
Purpose: Despite achieving sustained virologic response (SVR) after treatment with direct-acting antivirals (DAAs), patients with hepatitis C virus (HCV)-related cirrhosis remain at risk of hepatocellular carcinoma (HCC) ...
Observational Study
Journal of gastrointestinal cancer. 2026 Jan 9;57(1):6. DOI:10.1007/s12029-025-01371-0 2026
The Evolving Landscape of Colorectal Cancer: Aging Burden and Metabolic Risk Factors in China (1990-2021) [0.03%]
中国结直肠癌的演变格局（1990-2021年）：老龄化负担和代谢危险因素
Yujie Han,Xiangkun Huan,Rui Zhu et al.
Yujie Han et al.
Objective: To analyze the long-term trends, age- and sex-specific patterns, and attributable risk factors of the colorectal cancer (CRC) burden in the Chinese population aged ≥ 60 years from 1990 to 2021, so as to provid...
Epidemiologic Trends in Secondary Malignant Neoplasms of the Liver in the United States: A 25-Year National Study [0.03%]
美国肝脏继发性恶性肿瘤的流行病学趋势：一项为期25年的全国研究报告
Mahnoor Khan,Daniyal Ali Khan,Kantesh Kumar et al.
Mahnoor Khan et al.
Purpose: Secondary malignant neoplasms of the liver are more common than primary liver cancers but remain understudied. This study provides the first nationwide analysis of liver metastases-related mortality trends and di...
The Vascular Density/Angiogenesis Marker CD31/PECAM1 does not Correlate with Overall Survival in Neuroendocrine Tumors [0.03%]
神经内分泌肿瘤的总生存期与血管密度/新生血管标志物CD31/PECAM1无关
Nicholas J Skill,Kenneth Avanzino,Yvette Bren-Mattison et al.
Nicholas J Skill et al.
Neuroendocrine neoplasms (NENs) are rare cancers. CD31/PECAM1 is an adhesion molecule that modulates endothelial cell-to-cell contact. Increased CD31 expression is a marker for tumor growth, and cancer aggressiveness. The purpose of this st...